252 related articles for article (PubMed ID: 31894806)
1. In situ analysis of liposome hard and soft protein corona structure and composition in a single label-free workflow.
Kari OK; Ndika J; Parkkila P; Louna A; Lajunen T; Puustinen A; Viitala T; Alenius H; Urtti A
Nanoscale; 2020 Jan; 12(3):1728-1741. PubMed ID: 31894806
[TBL] [Abstract][Full Text] [Related]
2. Multi-parametric surface plasmon resonance platform for studying liposome-serum interactions and protein corona formation.
Kari OK; Rojalin T; Salmaso S; Barattin M; Jarva H; Meri S; Yliperttula M; Viitala T; Urtti A
Drug Deliv Transl Res; 2017 Apr; 7(2):228-240. PubMed ID: 27491413
[TBL] [Abstract][Full Text] [Related]
3. Tuning liposome composition to modulate corona formation in human serum and cellular uptake.
Yang K; Mesquita B; Horvatovich P; Salvati A
Acta Biomater; 2020 Apr; 106():314-327. PubMed ID: 32081780
[TBL] [Abstract][Full Text] [Related]
4. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation.
Putri AD; Hsu MJ; Han CL; Chao FC; Hsu CH; Lorenz CD; Hsieh CM
Nanoscale; 2023 Nov; 15(44):17825-17838. PubMed ID: 37850423
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles.
Hadjidemetriou M; Al-Ahmady Z; Mazza M; Collins RF; Dawson K; Kostarelos K
ACS Nano; 2015 Aug; 9(8):8142-56. PubMed ID: 26135229
[TBL] [Abstract][Full Text] [Related]
6. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
7. Effects of the protein corona on liposome-liposome and liposome-cell interactions.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Sherman MB; Parodi A; Salvatore F; Tasciotti E
Int J Nanomedicine; 2016; 11():3049-63. PubMed ID: 27445473
[TBL] [Abstract][Full Text] [Related]
8. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
9. Variations in metabolite profiles of serum coronas produced around PEGylated liposomal drugs by surface property.
Jang GJ; Jeong JY; Joung H; Han SY
Colloids Surf B Biointerfaces; 2023 Oct; 230():113488. PubMed ID: 37574616
[TBL] [Abstract][Full Text] [Related]
10. Surface chemistry and serum type both determine the nanoparticle-protein corona.
Pozzi D; Caracciolo G; Capriotti AL; Cavaliere C; La Barbera G; Anchordoquy TJ; Laganà A
J Proteomics; 2015 Apr; 119():209-17. PubMed ID: 25731725
[TBL] [Abstract][Full Text] [Related]
11. The protein corona of circulating PEGylated liposomes.
Palchetti S; Colapicchioni V; Digiacomo L; Caracciolo G; Pozzi D; Capriotti AL; La Barbera G; Laganà A
Biochim Biophys Acta; 2016 Feb; 1858(2):189-96. PubMed ID: 26607013
[TBL] [Abstract][Full Text] [Related]
12. How protein coronas determine the fate of engineered nanoparticles in biological environment.
Capjak I; Goreta SŠ; Jurašin DD; Vrček IV
Arh Hig Rada Toksikol; 2017 Dec; 68(4):245-253. PubMed ID: 29337683
[TBL] [Abstract][Full Text] [Related]
13. Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients.
Colapicchioni V; Tilio M; Digiacomo L; Gambini V; Palchetti S; Marchini C; Pozzi D; Occhipinti S; Amici A; Caracciolo G
Int J Biochem Cell Biol; 2016 Jun; 75():180-7. PubMed ID: 26369869
[TBL] [Abstract][Full Text] [Related]
14. Liposome protein corona characterization as a new approach in nanomedicine.
Capriotti AL; Cavaliere C; Piovesana S
Anal Bioanal Chem; 2019 Jul; 411(19):4313-4326. PubMed ID: 30758528
[TBL] [Abstract][Full Text] [Related]
15. Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers.
Corbo C; Molinaro R; Taraballi F; Toledano Furman NE; Hartman KA; Sherman MB; De Rosa E; Kirui DK; Salvatore F; Tasciotti E
ACS Nano; 2017 Mar; 11(3):3262-3273. PubMed ID: 28264157
[TBL] [Abstract][Full Text] [Related]
16. The biomolecular corona of nanoparticles in circulating biological media.
Pozzi D; Caracciolo G; Digiacomo L; Colapicchioni V; Palchetti S; Capriotti AL; Cavaliere C; Zenezini Chiozzi R; Puglisi A; Laganà A
Nanoscale; 2015 Sep; 7(33):13958-66. PubMed ID: 26222625
[TBL] [Abstract][Full Text] [Related]
17. Impact of the biomolecular corona on the structure of PEGylated liposomes.
Digiacomo L; Pozzi D; Amenitsch H; Caracciolo G
Biomater Sci; 2017 Aug; 5(9):1884-1888. PubMed ID: 28676869
[TBL] [Abstract][Full Text] [Related]
18. The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.
Hadjidemetriou M; McAdam S; Garner G; Thackeray C; Knight D; Smith D; Al-Ahmady Z; Mazza M; Rogan J; Clamp A; Kostarelos K
Adv Mater; 2019 Jan; 31(4):e1803335. PubMed ID: 30488990
[TBL] [Abstract][Full Text] [Related]
19. Deciphering Protein Corona by scFv-Based Affinity Chromatography.
Chu Y; Tang W; Zhang Z; Li C; Qian J; Wei X; Ying T; Lu W; Zhan C
Nano Lett; 2021 Mar; 21(5):2124-2131. PubMed ID: 33617264
[TBL] [Abstract][Full Text] [Related]
20. Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties
Giulimondi F; Vulpis E; Digiacomo L; Giuli MV; Mancusi A; Capriotti AL; Laganà A; Cerrato A; Zenezini Chiozzi R; Nicoletti C; Amenitsch H; Cardarelli F; Masuelli L; Bei R; Screpanti I; Pozzi D; Zingoni A; Checquolo S; Caracciolo G
ACS Nano; 2022 Feb; 16(2):2088-2100. PubMed ID: 35040637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
